NEUROCRINE BIOSCIENCES INC
NBIX
71 insider filings · Latest: Sep 11, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Feb 10, 2025 | Feb 10 9:31 PM | EIRY WYN ROBERTS | Proposed Sale | 980 | $122.62 | $120.2K | — | View → |
| Feb 10, 2025 | Feb 10 9:30 PM | MATTHEW C ABERNETHY | Proposed Sale | 980 | $122.62 | $120.2K | — | View → |
| Feb 3, 2025 | Feb 3 9:19 PM | INGRID DELAET | Proposed Sale | 623 | $151.82 | $94.6K | — | View → |
| Jan 31, 2025 | Jan 31 9:34 PM | JULIE COOKE | Proposed Sale | 824 | $153.29 | $126.3K | — | View → |
| Jan 31, 2025 | Jan 31 9:33 PM | KEVIN CHARLES GORMAN | Proposed Sale | 2,707 | $153.29 | $415.0K | — | View → |
| Jan 31, 2025 | Jan 31 9:32 PM | EIRY WYN ROBERTS | Proposed Sale | 1,457 | $153.29 | $223.3K | — | View → |
| Jan 31, 2025 | Jan 31 9:32 PM | INGRID DELAET | Proposed Sale | 422 | $153.29 | $64.7K | — | View → |
| Jan 31, 2025 | Jan 31 9:31 PM | KYLE GANO | Proposed Sale | 1,541 | $153.29 | $236.2K | — | View → |
| Jan 31, 2025 | Jan 31 9:29 PM | MATTHEW C ABERNETHY | Proposed Sale | 1,283 | $153.29 | $196.7K | — | View → |
| Jan 31, 2025 | Jan 31 9:29 PM | ERIC BENEVICH | Proposed Sale | 1,207 | $153.29 | $185.0K | — | View → |
| Jan 31, 2025 | Jan 31 9:28 PM | DAVID WARREN BOYER | Proposed Sale | 1,104 | $153.29 | $169.2K | — | View → |
| Jan 31, 2025 | Jan 31 9:28 PM | DARIN LIPPOLDT | Proposed Sale | 1,250 | $153.29 | $191.6K | — | View → |
| Jan 31, 2025 | Jan 31 9:28 PM | JULIE COOKE | Proposed Sale | 916 | $153.29 | $140.4K | — | View → |
| Jan 31, 2025 | Jan 31 9:27 PM | JUDE ONYIA | Proposed Sale | 126 | $153.29 | $19.3K | — | View → |
| Jan 27, 2025 | Jan 27 9:27 PM | KEVIN CHARLES GORMAN | Proposed Sale | 146,105 | $148.73 | $21.7M | — | View → |
| Jan 15, 2025 | Jan 15 9:19 PM | KYLE W GANO | Proposed Sale | 65,000 | $139.51 | $9.1M | — | View → |
| Dec 31, 2024 | Dec 31 9:17 PM | INGRID DELAET | Proposed Sale | 272 | $137.06 | $37.3K | — | View → |
| Dec 17, 2024 | Dec 17 9:29 PM | INGRID DELAET | Proposed Sale | 1,091 | $133.05 | $145.2K | — | View → |
| Nov 29, 2024 | Nov 29 6:41 PM | JUDE ONYIA | Proposed Sale | 2,331 | $126.59 | $295.1K | — | View → |
| Sep 13, 2024 | Sep 13 8:23 PM | DAVID WARREN BOYER | Proposed Sale | 4,756 | $121.28 | $576.8K | — | View → |
← Previous
Page 5 of 5
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 13, 2026 | Feb 17 10:44 PM | Kevin Charles GormanDirector | Option Exercise | 10,981 | — | 5,377(D) | View → |
| Feb 13, 2026 | Feb 17 10:44 PM | Sanjay Chandru KeswaniChief Medical Officer | Grant/Award | 42,112 | $124.12 | 6,285(D) | View → |
| Jan 31, 2026 | Feb 3 11:22 PM | David W. BoyerChief Corp. Affairs Officer | Option Exercise | 2,096 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 11:21 PM | Eric BenevichChief Commercial Officer | Option Exercise | 2,294 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 11:06 PM | Matt AbernethyChief Financial Officer | Option Exercise | 2,437 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 11:05 PM | Julie CookeChief Human Resources Officer | Option Exercise | 1,741 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 11:04 PM | Ingrid DelaetChief Regulatory Officer | Option Exercise | 801 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 11:03 PM | Kyle GanoDirector, Chief Executive Officer | Option Exercise | 2,927 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 11:02 PM | Kevin Charles GormanDirector | Option Exercise | 5,142 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 11:01 PM | Darin LippoldtChief Legal Officer | Option Exercise | 2,373 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 11:01 PM | Jude OnyiaChief Scientific Officer | Option Exercise | 238 | — | 0(D) | View → |
| Jan 16, 2026 | Jan 20 11:56 PM | Kyle GanoDirector, Chief Executive Officer | Option Exercise | 36,400 | $35.99 | 0(D) | View → |
← Previous
Page 4 of 4